8-K filing — INCYTE CORP (INCY)
Filed: 2026-08-31 AccNo: 0000879169-26-000058 Size: 135 KB Item 8.01: Other Events
Stocks · News reference
Incyte Announces Agreement With CMS To Offer Jakafi And Jakafi XR To State Medicaid Programs At Prices Aligned With Other Industrialized Nations; Says It Does Not Expect Impact To 2026 Guidance
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Canaccord Genuity Initiates Coverage On Incyte with Buy Rating, Announces Price Target of $152
Canaccord Genuity analyst John Newman initiates coverage on Incyte (NASDAQ:INCY) with a Buy rating and announces Price Target of $152.
HC Wainwright & Co. Reiterates Buy on Incyte, Maintains $150 Price Target
HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Incyte (NASDAQ:INCY) with a Buy and maintains $150 price target.